Tevogen Operating Cash Flow Growth & History (TVGN)

Tevogen's operating cash flow was −$12.3M for fiscal 2025.

View full Tevogen company overview

Tevogen annual operating cash flow history

Tevogen annual operating cash flow

Fiscal yearPeriod endedOperating cash flowChangeGrowth
20252025-12-31−$12.3M−$329,847
20242024-12-31−$12.0M−$3.8M
20232023-12-31−$8.2M−$8.0M
20222022-12-31−$215,395$498,431
20212021-12-31−$713,826

Tevogen operating cash flow trends

Between the periods ended 2021-12-31 and 2025-12-31, Tevogen's operating cash flow decreased from −$713,826 to −$12.3M, a change of −$11.6M. The latest reported quarter, Q2 2026, shows −$3.0M.

About the metric

What operating cash flow means

Operating cash flow is the cash generated or used by a company’s core operations. It incorporates working-capital movements and other operating cash items, and it is the starting point for calculating free cash flow.

Calculation and source

SEC-reported operating cash flow

TickerStat standardizes net cash provided by or used in operating activities reported in company SEC filings. It is historical filing data before capital expenditures, financing activities, and investing activities. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Tevogen source filings ↗

Community posts

It’s quiet here.

No posts about TVGN yet. Start the conversation.

Write the first post